Foresee Pharmaceuticals Co., Ltd. (TPEX:6576)
79.10
0.00 (0.00%)
Apr 2, 2025, 1:30 PM CST
Foresee Pharmaceuticals Revenue
In the year 2024, Foresee Pharmaceuticals had annual revenue of 418.69M TWD with 114.67% growth. Foresee Pharmaceuticals had revenue of 140.55M in the quarter ending December 31, 2024, with 105.41% growth.
Revenue
418.69M
Revenue Growth
+114.67%
P/S Ratio
25.94
Revenue / Employee
n/a
Employees
n/a
Market Cap
12.24B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 418.69M | 223.65M | 114.67% |
Dec 31, 2023 | 195.04M | -106.47M | -35.31% |
Dec 31, 2022 | 301.51M | 75.48M | 33.39% |
Dec 31, 2021 | 226.03M | -4.41M | -1.91% |
Dec 31, 2020 | 230.44M | 155.24M | 206.44% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
PharmaEssentia | 9.73B |
Caliway Biopharmaceuticals | 44.43M |
Bora Pharmaceuticals Co., LTD. | 19.25B |
Lotus Pharmaceutical | 18.58B |
Oneness Biotech | 117.93M |
Lumosa Therapeutics | 39.15M |
Pegavision | 6.82B |
Polaris Group | 107.00M |